Literature DB >> 24901728

Co-existence of cutaneous leishmaniasis with pleural effusion: a case report from Iran.

Hossein Mortazavi1, Tahereh Soori2, Ali Khamesipour3, Alireza Khatami4, Amir Vasheghani-Farahani4.   

Abstract

Herein, a 12-year-old Afghan boy with chronic cutaneous leishmaniasis on the face and verrucous lesions on the body and pleural effusion suspected of having co-existent tuberculosis has been presented. The cutaneous lesions were appeared for five years before his admission. Leishman-Donovan bodies were seen in H&E (Hematoxylin and eosin) slide of skin lesion specimens. The pathogenic species was proved to be Leishmania tropica using Polymerase Chain Reaction (PCR) method. Purified Protein Derivative (PPD) and Leishmanin Skin Test (LST) were strongly positive. The patient was treated with systemic and intralesional meglumine antimoniate (Glucantime) for cutaneous leishmaniasis and then with anti-tuberculosis drugs for pleural effusion. Afterwards, pleural effusion was disappeared and cutaneous leishmaniasis cured.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24901728

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  3 in total

1.  Evaluation of a point-of-care molecular detection device for Leishmania spp. and intercurrent fungal and mycobacterial organisms in Peruvian patients with cutaneous ulcers.

Authors:  Ruwandi Kariyawasam; Braulio M Valencia; Rachel Lau; Eric Shao; Courtney A Thompson; Michael Stevens; Leah Kincaid; Ana Luz Quispe Del Castillo; Lloysi O Cruz-Arzapalo; Alejandro Llanos-Cuentas; Andrea K Boggild
Journal:  Infection       Date:  2021-08-08       Impact factor: 3.553

Review 2.  Tegumentary leishmaniasis and coinfections other than HIV.

Authors:  Dalila Y Martínez; Kristien Verdonck; Paul M Kaye; Vanessa Adaui; Katja Polman; Alejandro Llanos-Cuentas; Jean-Claude Dujardin; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2018-03-01

3.  Leishmaniasis as a Neglected Cause of Isolated Lymphadenopathy: A Case Report.

Authors:  Eslam Shorafa; Gholamreza Poladfar; Roholla Adelian; Mahmood Shariat; Mohammad Reza Minaee; Syeed Mohammad Hashemi; Maryam Tazang
Journal:  Iran J Public Health       Date:  2016-07       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.